Latham & Watkins LLP represented Purigen in the transaction. Bionano Genomics, Inc. (NASDAQ: BNGO) has entered into a definitive agreement to acquire Purigen Biosystems, Inc., a...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here